Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests

This study has been completed.
Information provided by:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
First received: April 14, 2005
Last updated: January 20, 2009
Last verified: April 2007
The purpose of this study is to evaluate different diets and the effects of blood measures or inflammation and endothelial function in association with genetics tending to abnormal blood test levels.

Condition Intervention
Behavioral: Diet

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Clinical Implications of Genetic Alterations in TG Rich Lipoproteins

Resource links provided by NLM:

Further study details as provided by VA Office of Research and Development:

Study Start Date: January 2005
Estimated Study Completion Date: December 2007

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Polymorphism in Apo C3 promoter and normal controls.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00108212

United States, Maryland
VA Maryland Health Care System
Baltimore, Maryland, United States, 21201
Sponsors and Collaborators
VA Office of Research and Development
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00108212     History of Changes
Other Study ID Numbers: CARD-005-03S
Study First Received: April 14, 2005
Last Updated: January 20, 2009
Health Authority: United States: Federal Government

Keywords provided by VA Office of Research and Development:
Genetic polymorphism

Additional relevant MeSH terms:
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on November 27, 2015